Inhibrx Biosciences Inc. (INBX)
NASDAQ: INBX
· Real-Time Price · USD
23.44
-0.50 (-2.09%)
At close: Aug 15, 2025, 3:59 PM
23.33
-0.47%
After-hours: Aug 15, 2025, 04:34 PM EDT
Inhibrx Biosciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.4M | 200K | 200K | 1.73M | 1.85M | 1.78M | 1.8M | 440K | 599K | 1.28M | 2.18M | 4.74M | 6.97M | 7.18M | 7.13M | 7.07M | 10.38M | 12.8M |
Cost of Revenue | 801K | 1.28M | 961K | 1.89M | 573K | 829K | 1.19M | 1.61M | 2.89M | 32.07M | 31.34M | 30.63M | 29.91M | n/a | 16.44M | 16.44M | 36.27M | 55.25M |
Gross Profit | -701K | -1.08M | -761K | -160K | 1.28M | 954K | 609K | -1.17M | -2.29M | -30.79M | -29.17M | -25.89M | -22.94M | 7.18M | -9.31M | -9.37M | -25.89M | -42.45M |
Operating Income | -167.01M | -300.52M | -331.45M | -369.81M | -368.84M | -249.28M | -219.22M | -166.43M | -150.61M | -143.87M | -129.12M | -113.02M | -101.82M | -87.02M | -76.56M | -74.27M | -71.02M | -68.39M |
Interest Income | 9.35M | 9.96M | 10.94M | 13.63M | 13.06M | 12.74M | 14.51M | 15.16M | 18.18M | 15.77M | 10.69M | 5.34M | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -163.69M | 1.72B | 1.69B | 1.64B | 1.64B | -269.52M | -239.72M | -188.67M | -172.2M | -162.88M | -145.22M | -125.5M | -110.75M | -93.73M | -81.77M | -78.22M | -77.65M | -74.83M |
Net Income | -163.69M | 1.72B | 1.69B | 1.64B | 1.63B | -271.15M | -241.14M | -188.45M | -177.31M | -167.99M | -152.78M | -133.06M | -112.99M | -95.97M | -81.77M | -78.23M | -78.14M | -75.32M |
Selling & General & Admin | 37.01M | 123.95M | 127.8M | 118.93M | 118.91M | 32.81M | 29.34M | 26.87M | 24.33M | 22.47M | 21.12M | 19.45M | 16.95M | 14.4M | 12.36M | 10.93M | 9.7M | 8.38M |
Research & Development | 131.4M | 176.77M | 203.49M | 251.96M | 251.12M | 217.6M | 191.39M | 140M | 126.88M | 122.68M | 110.19M | 98.35M | 91.9M | 79.9M | 71.44M | 70.49M | 71.84M | 72.92M |
Other Expenses | -1.36M | -1.36M | -689K | n/a | -304K | -521K | -5.67M | -11.09M | -16.11M | -15.87M | -10.73M | -5.32M | 2K | -10K | 20K | 20K | -4.43M | -4.44M |
Operating Expenses | 167.05M | 299.36M | 330.6M | 370.88M | 369.73M | 250.1M | 220.42M | 166.57M | 151.21M | 145.15M | 131.29M | 117.76M | 108.79M | 94.2M | 83.69M | 81.33M | 81.41M | 81.19M |
Interest Expense | -5.83M | 2.67M | 13.49M | 21.71M | 29.86M | 32.41M | 29.36M | 26.48M | 23.67M | 18.91M | 16.11M | 12.54M | 8.98M | 6.75M | 5.22M | 3.97M | 6.62M | 9.11M |
Selling & Marketing Expenses | n/a | n/a | -104K | -150K | -150K | -150K | -46K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 139.73M | 300.72M | 331.65M | 371.54M | 370.69M | 251.06M | 221.02M | 166.87M | 151.21M | 145.15M | 131.29M | 117.76M | 108.79M | 94.2M | 83.69M | 81.33M | 81.41M | 81.19M |
Income Tax Expense | 2K | 2K | 318.72K | 314.72K | 316.72K | 319.72K | -222K | -219K | 5.1M | 5.1M | 7.56M | 7.56M | 2.24M | 2.24M | 2K | 5K | 492K | 492K |
Shares Outstanding (Basic) | 15.47M | 15.47M | 14.48M | 15.47M | 14.48M | 54.55M | 54.03M | 47.15M | 43.64M | 43.58M | 43.27M | 39.07M | 39.04M | 39.02M | 38.58M | 37.89M | 37.82M | 37.74M |
Shares Outstanding (Diluted) | 15.47M | 15.47M | 14.48M | 15.47M | 14.81M | 54.55M | 54.03M | 47.15M | 43.64M | 43.58M | 43.27M | 39.07M | 39.04M | 39.02M | 38.58M | 37.89M | 37.82M | 37.74M |
EPS (Basic) | -10.8 | 119.40 | 120.76 | 122.34 | 124.08 | -5.35 | -5.03 | -4.25 | -4.19 | -4.08 | -3.82 | -3.42 | -2.92 | -2.5 | -2.15 | -2.07 | -2.3 | -2.25 |
EPS (Diluted) | -10.8 | 116.53 | 117.89 | 119.47 | 121.21 | -5.35 | -5.03 | -4.25 | -4.19 | -4.08 | -3.82 | -3.42 | -2.92 | -2.5 | -2.15 | -2.07 | -2.3 | -2.25 |
EBITDA | -160.57M | 1.73B | 1.7B | 1.66B | 1.66B | -240.39M | -211.23M | -158.74M | -145.41M | -140.83M | -128.45M | -112.35M | -100.85M | -86.08M | -75.66M | -73.36M | -70.41M | -67.84M |
EBIT | -132.35M | 1.73B | 1.7B | 1.66B | 1.66B | -241.65M | -212.42M | -159.7M | -146.05M | -141.49M | -129.12M | -112.95M | -101.77M | -86.99M | -76.55M | -74.25M | -71.03M | -65.72M |
Depreciation & Amortization | 2.12M | 2.6M | 2.29M | 1.89M | 1.44M | 1.69M | 1.63M | 2.05M | 2.46M | 2.06M | 2.11M | 1.69M | 1.27M | 1.25M | 1.2M | 1.15M | 1.1M | 1.05M |